30
Participants
Start Date
January 20, 2021
Primary Completion Date
April 20, 2021
Study Completion Date
May 10, 2021
Liraglutide
Liraglutide is a glucagon-like peptide type 1 (GLP-1) analogue. We had fond its cognitive improvement effects in an observational study. In order to confirm the effects, the investigators conduct a randomized, controlled study.
Oral antidiabetic drugs: Metformin, Sulfonylureas (2nd generation), Thiazolidinediones, α-Glucosidase inhibitors, and Glinides
oral antidiabetic drugs (OADs) or insulin, except for glucagon-like peptide type 1 (GLP-1) analogues
The third hospital affiliated to the Third Military Medical University, Chongqing
Third Military Medical University
OTHER